Department of Neuroscience
monashstmneuro.bsky.social
Department of Neuroscience
@monashstmneuro.bsky.social
We are passionate about neuroscience. We have more than 25 individual research groups, with our major areas of research including multiple sclerosis, epilepsy and brain injury. We have over 200 staff members and 86 higher degree and honours students.
Congratulations to postdoc clinician Dr Parveen Sagar @monashuniversity.bsky.social @alfredhealth.bsky.social who has been awarded a Brain Foundation grant for making epilepsy surgery safer for people's speech post-surgery 👏🤩#epilepsy #neurology #earlycareer

brainfoundation.org.au/research-gra...
Making Epilepsy Surgery Safer for Speech and Communication - Brain Foundation
brainfoundation.org.au
November 12, 2025 at 3:46 AM
🥳Congratulations to postdoc clinician Dr Tracie Tan
@monashuniversity.bsky.social @alfredhealth.bsky.social awarded a Brain Foundation grant for her work in understanding the role of #neuroinflammatory pathways in drug-resistant #epilepsy🧠 Visit and watch here brainfoundation.org.au/research-gra...
Association of brain fluid inflammation related proteins and drug-resistant epilepsy - Brain Foundation
brainfoundation.org.au
November 11, 2025 at 3:17 AM
One of our brilliant researchers Dr Emma Foster @monashuniversity.bsky.social gave a rundown of her @nhmrc.bsky.social investigator grant tackling #epilepsy 4 @alfredhealth.bsky.social Research Week, better health care for Australians & improvements to the economy, hosted by @drshanerrr.bsky.social
October 28, 2025 at 3:27 AM
Today we had our first early-mid career researcher learning development session presented by Prof Amy Brodtmann @monashuniversity.bsky.social about how to get your paper published. Key take away - Make your science clear, convoluted and complex does NOT equal clever! #scicomm #EMCR #academia
October 27, 2025 at 3:15 AM
🚨New study: Gray matter volume (GMV) changes on MRI correlate with SEEG-defined epileptogenic zones in drug-resistant epilepsy—especially in MRI-positive cases. GMV might just be the non-invasive biomarker we've been waiting for. #Epilepsy #Neuroimaging #SEEG #Neuroscience doi.org/10.1111/epi....
Association between local gray matter volume differences and stereo‐electroencephalography‐defined epileptogenicity
Objective The yield of voxel-based gray matter volume (GMV) quantification to identify the epileptogenic zone (EZ) remained moderate, which may be due to the choice of “ground truth.” We explored wh...
doi.org
October 24, 2025 at 5:51 AM
🧠🎧Hear more fromA/Professor Pablo Casillas-Espinosa
@monashuniversity.bsky.social talking with @vjneurology.bsky.social at the recent #IEC2025 in Portugal about biases in #neuroscience research and pushes for more understanding on sex difference in #epilepsy youtu.be/LJzDFxNG96M 4 min listen time
Bias in neuroscience research and the lack of research on sex differences in epilepsy
YouTube video by VJNeurology
youtu.be
October 15, 2025 at 10:59 PM
Dr Jingni He, one of our research fellows has been selected for one of Illumina's coveted awards, the 2025 Neurogenomics research award for #multiplesclerosis🏅#neuroscience #genomics Read more - sapac.illumina.com/company/news...
A recent multiomics pilot study unlocks the mystery of MS and pregnancy remission
sapac.illumina.com
October 15, 2025 at 3:57 AM
“The menopausal transition can be challenging for many women. This study gives women with MS one less thing to be concerned about", said Dr Francesca Bridge. @vjokubaitis.bsky.social @monashuniversity.bsky.social @alfredhealth.bsky.social #multiplesclerosis #menopause www.monash.edu/news/article...
October 1, 2025 at 12:28 AM
NEW in @plosone.org promising #glioblastoma therapeutic target. Dr Matthew Drill & team
@masturamonif.bsky.social @monashuniversity.bsky.social
reveal an alternative pathway with selective targeting to complement existing treatments and/or offer new treatment doi.org/10.1371/jour... #neuroscience
Purinergic P2X receptor 7 (P2X7R) inhibition induced cytotoxicity in glioblastoma
Glioblastoma is the most common and aggressive form of primary brain cancer with a median survival of 15 months from diagnosis. The purinergic receptor P2X7 (P2X7R) is a regulator of several cell sign...
doi.org
September 19, 2025 at 4:54 AM
🧠Check out this interactive overview featuring #dementia research from @monashuniversity.bsky.social researchers, including our own Professor Amy Brodtmann #publichealth
lens.monash.edu/2025/09/11/1...
The hunt for dementia’s hidden clues
Dementia cases are surging globally, with more than 55 million people affected and nearly 10 million new diagnoses annually. Researchers are urgently decoding its hidden biological clues to combat thi...
lens.monash.edu
September 18, 2025 at 9:06 AM
🧠🕒Simple clock drawing test could revolutionize how we detect brain toxicity in cancer immunotherapy patients, Early detection = faster treatment #CancerTreatment #Neurology #cognition @masturamonif.bsky.social @monashuniversity.bsky.social @alfredhealth.bsky.social www.monash.edu/medicine/new...
Simple drawing test could be key to identifying brain toxicity from cancer immunotherapy
Immunotherapy has revolutionised the treatment of blood cancers. But in anywhere up to two-thirds of patients, it can cause severe, even life-threatening neurological symptoms.
www.monash.edu
September 4, 2025 at 12:47 AM
🎧This episode featuring our deputy head of department @vjokubaitis.bsky.social @monashuniversity.bsky.social is full of fascinating insights, stories, important tips, and updates for the #multiplesclerosis community in celebration of #womenshealthweek
www.msaustralia.org.au/raw-nerve/65...
Women’s Health and MS: Marking Women’s Health Week 2025 - MS Australia
Join us for a special episode on women’s health and MS, hosted by Dr Tennille Luker, MS Australia’s Head of Research, exploring diagnosis and lived experience, mental health, work and chronic illness,...
www.msaustralia.org.au
September 2, 2025 at 3:41 AM
NEW BOOK - The 3rd edition of the Stroke Medicine handbook, authored by one of our researchers Professor Geoffrey Cloud is now available to buy on Amazon, perfect for #stroke trainees and specialists for use in everyday practice - www.amazon.com.au/Stroke-Medic...
Stroke Medicine Oxford Specialist Handbook 3e : Markus, Pereira, Cloud: Amazon.com.au: Books
Stroke Medicine Oxford Specialist Handbook 3e : Markus, Pereira, Cloud: Amazon.com.au: Books
www.amazon.com.au
August 19, 2025 at 4:09 AM
Reposted by Department of Neuroscience
2025 Student and ECR virtual symposium. Thursday, 21st August, between 11am - 3pm AEST. Register for FREE: linktr.ee/ASCEPTDDNRIS...
August 19, 2025 at 3:50 AM
Congratulations to #PhD student Merran Courtney @monashstm-grsc.bsky.social who has presented her final oration today looking at the use of neuroimaging to predict patients who become seizure-free following #epilepsy surgery - super exciting, pictured here with her supervisors 🤩👏
August 18, 2025 at 4:27 AM
📢Congrats to #Research Fellow Dr Sharon Kramer @monashuniversity.bsky.social who has received our inaugural Early Career Researcher Travel Grant! She will present findings from her project EXIST-Rehab @worldstrokeorg.bsky.social #WSC2025 conference in Spain & speak at an International roundtable
August 14, 2025 at 5:34 AM
Reposted by Department of Neuroscience
Drawing the mind, one neuron at a time: A 2022 book walks readers through the life and work of Santiago Ramón y Cajal, the Spaniard whom many consider the founder of modern #neuroscience.

Check out the #ScienceBooks Review on #BookLoversDay: scim.ag/3RvHDmQ
August 9, 2025 at 2:07 PM
Scientists from our dept @monashuniversity.bsky.social have developed a human stem cell–based seizure model using electrical stimulation⚡opening the door to personalised epilepsy treatment! 🧠

A big step for #Neurotech and #EpilepsyResearch.
🔗 doi.org/10.1111/epi....
#StemCells #DrugDiscovery
Electrical stimulation of stem cell–derived human neural networks for evaluating anti‐seizure medications
Objective Current preclinical epilepsy drug screening relies on animal models that poorly reflect human neurophysiology, leading to high failure rates in clinical translation. We aimed to establish ...
doi.org
August 12, 2025 at 1:19 AM
🎆Exciting news this #NationalStrokeWeek - The TOSCAA-TXA is a new first in disease #clinicaltrial @alfredhealth.bsky.social for patients over 50 years with cerebral amyloid angiopathy, a type of #stroke. The team has just recruited five patients in the first month 🤩👏 #translational #research
August 7, 2025 at 4:21 AM
It's #NationalStrokeWeek Know the #FASTsigns One of our researchers @natashalannin.bsky.social @alfredhealth.bsky.social spoke to us about their team's recent WHO STARS report and its impact on stroke care & research 👇. Read the report here - doi.org/10.1007/s401... #StrokeFoundation #BrainHealth
August 6, 2025 at 3:54 AM
Reposted by Department of Neuroscience
Thrilled for my plenary presentation of HOME-Rehab to a global audience at #ESOC2025! 🚀 >4000 delegates, great discussions & positive reception. Excited about potential impact of our findings on stroke rehab! #ClinicalTrials #StrokeRecovery
@esostroke.bsky.social @monashstmneuro.bsky.social
May 24, 2025 at 4:01 AM
Great to have visiting #PhD student and physiotherapist Vibeke Wagner join the Brain Recovery and Rehab group @natashalannin.bsky.social @monashuniversity.bsky.social at their monthly meeting talking about her work with robotics in #stroke - very cool! #researchinaction #braininjury
April 17, 2025 at 1:52 AM
Congrats to Dr. Madeleine Smith @monashuniversity.bsky.social who received an Int Stroke Recovery and Rehabilitation Alliance (ISRRA) grant!🎉 She'll collaborate with Prof. Numa Dancause at Uni of Montreal to advance stroke recovery research using stem cell therapies🌟 #Neuroscience #StrokeResearch
April 16, 2025 at 5:57 AM
Amazing to see our colleagues @alfredhealth.bsky.social enabling new treatments for people with #Parkinsons through dedicated #ClinicalTrial beds - watch as Dr Kelly Bertram and team work with ShakeItUp Australia and the Michael J Fox Org to progress research www.alfredhealth.org.au/the-alfred-f...
April 15, 2025 at 2:51 AM